Welcome to LookChem.com Sign In|Join Free

CAS

  • or
3,4-(Methylenedioxy)cinnamic acid is a white to light yellow granular powder that acts as an inhibitor of the phenylpropanoid enzyme 4-hydroxycinnamoyl-CoA ligase. It is known for its ability to undergo electron transfer reactions with trichloromethylperoxyl radicals, a process that has been studied through pulse radiolysis.

2373-80-0 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 2373-80-0 Structure
  • Basic information

    1. Product Name: 3,4-(Methylenedioxy)cinnamic acid
    2. Synonyms: 3-(Benzo[d][1,3]dioxol-5-yl)acrylic acid;3,4-(Methylenedioxy)cinnamic acid, predominantly trans 99%;(E)-3-BENZO[1,3]DIOXOL-5-YL-ACRYLIC ACID;3-BENZO[1,3]DIOXOL-5-YL-ACRYLIC ACID;3-PIPERONYLACRYLIC ACID;AKOS B004102;AKOS AUF01566;AKOS BBS-00006476
    3. CAS NO:2373-80-0
    4. Molecular Formula: C10H8O4
    5. Molecular Weight: 192.17
    6. EINECS: 219-151-0
    7. Product Categories: Aromatic Cinnamic Acids, Esters and Derivatives;Cinnamic acid;C10;Carbonyl Compounds;Carboxylic Acids;Building Blocks;Carbonyl Compounds;Carboxylic Acids;Chemical Synthesis;Organic Building Blocks
    8. Mol File: 2373-80-0.mol
  • Chemical Properties

    1. Melting Point: 242-244 °C (dec.)(lit.)
    2. Boiling Point: 248.14°C (rough estimate)
    3. Flash Point: 148.9oC
    4. Appearance: white to light yellow granular powder
    5. Density: 1.0825 (rough estimate)
    6. Vapor Pressure: 7.39E-06mmHg at 25°C
    7. Refractive Index: 1.4440 (estimate)
    8. Storage Temp.: Inert atmosphere,Room Temperature
    9. Solubility: very faint turbidity in Pyridine
    10. PKA: 4.37±0.10(Predicted)
    11. BRN: 84599
    12. CAS DataBase Reference: 3,4-(Methylenedioxy)cinnamic acid(CAS DataBase Reference)
    13. NIST Chemistry Reference: 3,4-(Methylenedioxy)cinnamic acid(2373-80-0)
    14. EPA Substance Registry System: 3,4-(Methylenedioxy)cinnamic acid(2373-80-0)
  • Safety Data

    1. Hazard Codes: Xi
    2. Statements: 38-36/37/38
    3. Safety Statements: 36-24/25-37-26
    4. WGK Germany: 3
    5. RTECS:
    6. HazardClass: IRRITANT
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 2373-80-0(Hazardous Substances Data)

2373-80-0 Usage

Uses

Used in Pharmaceutical Industry:
3,4-(Methylenedioxy)cinnamic acid is used as an enzyme inhibitor for its role in inhibiting the phenylpropanoid enzyme 4-hydroxycinnamoyl-CoA ligase. This inhibition can be beneficial in various pharmaceutical applications, such as the development of drugs targeting specific metabolic pathways or enzymes.
Used in Chemical Research:
As a compound that undergoes electron transfer reactions with trichloromethylperoxyl radicals, 3,4-(Methylenedioxy)cinnamic acid is used in chemical research to study the mechanisms and kinetics of such reactions. This can contribute to the understanding of various chemical processes and the development of new synthetic methods or applications.
Used in Material Science:
The electron transfer properties of 3,4-(Methylenedioxy)cinnamic acid may also find applications in material science, particularly in the development of new materials with specific electronic or optical properties. Its ability to participate in electron transfer reactions could be harnessed for creating materials with tailored characteristics for various applications.

Purification Methods

Crystallise the acid from glacial AcOH, EtOH (m 247o) or aqueous EtOH (m 240-242o), and it has m 242o after sublimation. [Beilstein 19 H 278, 19 II 299, 19 III/IV 3548.]

Check Digit Verification of cas no

The CAS Registry Mumber 2373-80-0 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,3,7 and 3 respectively; the second part has 2 digits, 8 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 2373-80:
(6*2)+(5*3)+(4*7)+(3*3)+(2*8)+(1*0)=80
80 % 10 = 0
So 2373-80-0 is a valid CAS Registry Number.
InChI:InChI=1/C10H8O4/c11-10(12)4-2-7-1-3-8-9(5-7)14-6-13-8/h1-5H,6H2,(H,11,12)/p-1/b4-2+

2373-80-0 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (M0634)  3,4-Methylenedioxycinnamic Acid  >98.0%(HPLC)(T)

  • 2373-80-0

  • 25g

  • 570.00CNY

  • Detail
  • Alfa Aesar

  • (A10122)  3,4-(Methylenedioxy)cinnamic acid, predominantly trans, 99%   

  • 2373-80-0

  • 25g

  • 576.0CNY

  • Detail
  • Alfa Aesar

  • (A10122)  3,4-(Methylenedioxy)cinnamic acid, predominantly trans, 99%   

  • 2373-80-0

  • 100g

  • 1839.0CNY

  • Detail
  • Alfa Aesar

  • (A10122)  3,4-(Methylenedioxy)cinnamic acid, predominantly trans, 99%   

  • 2373-80-0

  • 500g

  • 8087.0CNY

  • Detail

2373-80-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name 3,4-(Methylenedioxy)cinnamic acid

1.2 Other means of identification

Product number -
Other names 3,4-Methoxy cinnaMic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:2373-80-0 SDS

2373-80-0Synthetic route

methyl (2E)-3-(1,3-benzodioxol-5-yl)acrylate
40918-96-5

methyl (2E)-3-(1,3-benzodioxol-5-yl)acrylate

3,4-methylenedioxy-trans-cinnamic acid
2373-80-0

3,4-methylenedioxy-trans-cinnamic acid

Conditions
ConditionsYield
Stage #1: methyl (2E)-3-(1,3-benzodioxol-5-yl)acrylate With water; sodium hydroxide In tetrahydrofuran
Stage #2: With hydrogenchloride In water pH=< 3;
99%
With sodium hydroxide In tetrahydrofuran; methanol at 40℃; Inert atmosphere;81%
With potassium hydroxide In ethanol; water Heating;15 mg
piperonal
120-57-0

piperonal

malonic acid
141-82-2

malonic acid

3,4-methylenedioxy-trans-cinnamic acid
2373-80-0

3,4-methylenedioxy-trans-cinnamic acid

Conditions
ConditionsYield
With aluminum oxide; lithium chloride for 0.1h; Doebner condensation; microwave irradiation;98%
With piperidine; pyridine for 1h; Knoevenagel-Doebner-Stobbe Reaction; Reflux;98%
With ammonium acetate for 0.0666667h; Irradiation;97%
piperonal
120-57-0

piperonal

acetic acid
64-19-7

acetic acid

3,4-methylenedioxy-trans-cinnamic acid
2373-80-0

3,4-methylenedioxy-trans-cinnamic acid

Conditions
ConditionsYield
Stage #1: piperonal; acetic acid With titanium tetrachloride In dichloromethane at 25℃; for 0.333333h; Inert atmosphere;
Stage #2: With triethylamine In dichloromethane at 25℃; Inert atmosphere; stereoselective reaction;
98%
(2RS,3SR)-2,3-dibromo-3-(3,4-methylenedioxyphenyl)propanoic acid

(2RS,3SR)-2,3-dibromo-3-(3,4-methylenedioxyphenyl)propanoic acid

3,4-methylenedioxy-trans-cinnamic acid
2373-80-0

3,4-methylenedioxy-trans-cinnamic acid

Conditions
ConditionsYield
With zinc In acetic acid at 20℃; for 0.0166667h; microwave irradiation;96%
3,4-methylenedioxycinnamic acid benzhydryl ester
85580-21-8

3,4-methylenedioxycinnamic acid benzhydryl ester

3,4-methylenedioxy-trans-cinnamic acid
2373-80-0

3,4-methylenedioxy-trans-cinnamic acid

Conditions
ConditionsYield
With formic acid at 40 - 45℃; for 0.5h; Product distribution;89%
(E)-2'-hydroxy-3,4-methylenedioxychalcone
16669-99-1

(E)-2'-hydroxy-3,4-methylenedioxychalcone

3,4-methylenedioxy-trans-cinnamic acid
2373-80-0

3,4-methylenedioxy-trans-cinnamic acid

Conditions
ConditionsYield
With dihydrogen peroxide; potassium carbonate In acetonitrile at 20℃; for 5h;89%
piperonal
120-57-0

piperonal

malonic acid
141-82-2

malonic acid

A

5-vinyl-1,3-benzodioxole
7315-32-4

5-vinyl-1,3-benzodioxole

B

3,4-methylenedioxy-trans-cinnamic acid
2373-80-0

3,4-methylenedioxy-trans-cinnamic acid

Conditions
ConditionsYield
With pyridine; acetic acid at 130℃; for 0.133333h; Knoevenagel-Doebner reaction; microwave irradiation;A 4 % Spectr.
B 85%
piperonal
120-57-0

piperonal

acetic anhydride
108-24-7

acetic anhydride

3,4-methylenedioxy-trans-cinnamic acid
2373-80-0

3,4-methylenedioxy-trans-cinnamic acid

Conditions
ConditionsYield
With potassium acetate for 6h; Heating;50%
With sodium acetate
wikstromol
117824-56-3

wikstromol

Sodium; 3-benzo[1,3]dioxol-5-yl-2-iodo-propionate

Sodium; 3-benzo[1,3]dioxol-5-yl-2-iodo-propionate

A

4-Benzenesulfonylamino-2-benzo[1,3]dioxol-5-ylmethyl-4-oxo-3-(3,4,5-trimethoxy-benzyl)-butyric acid
118975-42-1

4-Benzenesulfonylamino-2-benzo[1,3]dioxol-5-ylmethyl-4-oxo-3-(3,4,5-trimethoxy-benzyl)-butyric acid

B

3,4-methylenedioxy-trans-cinnamic acid
2373-80-0

3,4-methylenedioxy-trans-cinnamic acid

Conditions
ConditionsYield
With n-butyllithium 1) -78 --> 0 deg C, several hours; 2) -78 --> RT; Yield given. Multistep reaction;A n/a
B 30%
piperonal
120-57-0

piperonal

sodium acetate
127-09-3

sodium acetate

acetic anhydride
108-24-7

acetic anhydride

3,4-methylenedioxy-trans-cinnamic acid
2373-80-0

3,4-methylenedioxy-trans-cinnamic acid

piperonal
120-57-0

piperonal

malonic acid
141-82-2

malonic acid

acetic acid
64-19-7

acetic acid

3,4-methylenedioxy-trans-cinnamic acid
2373-80-0

3,4-methylenedioxy-trans-cinnamic acid

piperonal
120-57-0

piperonal

ethyl acetate
141-78-6

ethyl acetate

3,4-methylenedioxy-trans-cinnamic acid
2373-80-0

3,4-methylenedioxy-trans-cinnamic acid

Conditions
ConditionsYield
With sodium Behandeln mit methylalkoholischer Kalilauge;
piperonal
120-57-0

piperonal

malonic acid
141-82-2

malonic acid

dimethyl amine
124-40-3

dimethyl amine

A

3-benzo[1,3]dioxol-5-yl-3-methylamino-propionic acid

3-benzo[1,3]dioxol-5-yl-3-methylamino-propionic acid

B

3,4-methylenedioxy-trans-cinnamic acid
2373-80-0

3,4-methylenedioxy-trans-cinnamic acid

ethyl (E)-3-(benzo[d][1,3]dioxol-5-yl)acrylate
24393-66-6

ethyl (E)-3-(benzo[d][1,3]dioxol-5-yl)acrylate

3,4-methylenedioxy-trans-cinnamic acid
2373-80-0

3,4-methylenedioxy-trans-cinnamic acid

Conditions
ConditionsYield
With potassium hydroxide
With water; potassium hydroxide In tetrahydrofuran
3-(3,4,5-trimethoxyphenyl)propanoic acid
25173-72-2

3-(3,4,5-trimethoxyphenyl)propanoic acid

Sodium; 3-benzo[1,3]dioxol-5-yl-2-iodo-propionate

Sodium; 3-benzo[1,3]dioxol-5-yl-2-iodo-propionate

A

2-piperonyl-3-(3,4,5-trimethoxy-benzyl)-succinic acid
139747-16-3

2-piperonyl-3-(3,4,5-trimethoxy-benzyl)-succinic acid

B

3,4-methylenedioxy-trans-cinnamic acid
2373-80-0

3,4-methylenedioxy-trans-cinnamic acid

Conditions
ConditionsYield
With lithium diisopropyl amide Yield given;
piperonal
120-57-0

piperonal

malonic acid
141-82-2

malonic acid

ammonia
7664-41-7

ammonia

3,4-methylenedioxy-trans-cinnamic acid
2373-80-0

3,4-methylenedioxy-trans-cinnamic acid

3-benzo<1,3>dioxol-5-acrylic acid isobutylamide

3-benzo<1,3>dioxol-5-acrylic acid isobutylamide

3,4-methylenedioxy-trans-cinnamic acid
2373-80-0

3,4-methylenedioxy-trans-cinnamic acid

Conditions
ConditionsYield
With potassium hydroxide
ethanol
64-17-5

ethanol

dihydrogen peroxide
7722-84-1

dihydrogen peroxide

4-benzo[1,3]dioxol-5-yl-2-oxo-but-3-enoic acid
69662-23-3

4-benzo[1,3]dioxol-5-yl-2-oxo-but-3-enoic acid

KOH-solution

KOH-solution

3,4-methylenedioxy-trans-cinnamic acid
2373-80-0

3,4-methylenedioxy-trans-cinnamic acid

potassium salt of/the/ piperonylidenepyruvic acid

potassium salt of/the/ piperonylidenepyruvic acid

3,4-methylenedioxy-trans-cinnamic acid
2373-80-0

3,4-methylenedioxy-trans-cinnamic acid

Conditions
ConditionsYield
With ethanol; dihydrogen peroxide
piperonal
120-57-0

piperonal

malonic acid
141-82-2

malonic acid

ammonia
7664-41-7

ammonia

A

piperonylidene-malonic acid
4436-15-1

piperonylidene-malonic acid

B

3,4-methylenedioxy-trans-cinnamic acid
2373-80-0

3,4-methylenedioxy-trans-cinnamic acid

C

β-amino-β-<3.4-methylenedioxy-phenyl>-propionic acid

β-amino-β-<3.4-methylenedioxy-phenyl>-propionic acid

caffeic acid
331-39-5

caffeic acid

3,4-methylenedioxy-trans-cinnamic acid
2373-80-0

3,4-methylenedioxy-trans-cinnamic acid

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 304 mg / conc. H2SO4 / 1 h / Heating
2: K2CO3, Cu0 / dimethylformamide / 1 h / Heating
3: 15 mg / KOH / ethanol; H2O / Heating
View Scheme
Methyl caffeate
3843-74-1, 67667-67-8

Methyl caffeate

3,4-methylenedioxy-trans-cinnamic acid
2373-80-0

3,4-methylenedioxy-trans-cinnamic acid

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: K2CO3, Cu0 / dimethylformamide / 1 h / Heating
2: 15 mg / KOH / ethanol; H2O / Heating
View Scheme
Multi-step reaction with 2 steps
1: potassium carbonate / N,N-dimethyl-formamide / 110 °C / Inert atmosphere
2: sodium hydroxide / methanol; tetrahydrofuran / 40 °C / Inert atmosphere
View Scheme
3-(1,3 benzodioxol-5-yl)propionic acid
2815-95-4

3-(1,3 benzodioxol-5-yl)propionic acid

3,4-methylenedioxy-trans-cinnamic acid
2373-80-0

3,4-methylenedioxy-trans-cinnamic acid

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 1.) LDA, 2.) CBr4 / 1) THF, -78 deg C (45 min), 0 deg C (3 1/4 h), RT (1 h); 2) THF, -78 deg C, 2 h
2: 92 percent / KI / acetone / 24 h / Heating
3: NaH / 0 °C
4: 1.) LDA
View Scheme
Multi-step reaction with 4 steps
1: 1.) LDA, 2.) CBr4 / 1) THF, -78 deg C (45 min), 0 deg C (3 1/4 h), RT (1 h); 2) THF, -78 deg C, 2 h
2: 92 percent / KI / acetone / 24 h / Heating
3: NaH / 0 °C
4: 30 percent / 1.) n-BuLi / 1) -78 --> 0 deg C, several hours; 2) -78 --> RT
View Scheme
Multi-step reaction with 3 steps
1: 1.) LDA, 2.) iodine / 1) THF, -78 deg C (45 min), 0 deg C (3 1/4 h), RT (1 h); 2) THF, -78 deg C, 10 min
2: NaH / 0 °C
3: 1.) LDA
View Scheme
Multi-step reaction with 3 steps
1: 1.) LDA, 2.) iodine / 1) THF, -78 deg C (45 min), 0 deg C (3 1/4 h), RT (1 h); 2) THF, -78 deg C, 10 min
2: NaH / 0 °C
3: 30 percent / 1.) n-BuLi / 1) -78 --> 0 deg C, several hours; 2) -78 --> RT
View Scheme
3-(3,4-methylenedioxyphenyl)-2-bromopropionic acid
56183-75-6

3-(3,4-methylenedioxyphenyl)-2-bromopropionic acid

3,4-methylenedioxy-trans-cinnamic acid
2373-80-0

3,4-methylenedioxy-trans-cinnamic acid

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 92 percent / KI / acetone / 24 h / Heating
2: NaH / 0 °C
3: 1.) LDA
View Scheme
Multi-step reaction with 3 steps
1: 92 percent / KI / acetone / 24 h / Heating
2: NaH / 0 °C
3: 30 percent / 1.) n-BuLi / 1) -78 --> 0 deg C, several hours; 2) -78 --> RT
View Scheme
3-Benzo[1,3]dioxol-5-yl-2-iodo-propionic acid
118975-38-5

3-Benzo[1,3]dioxol-5-yl-2-iodo-propionic acid

3,4-methylenedioxy-trans-cinnamic acid
2373-80-0

3,4-methylenedioxy-trans-cinnamic acid

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: NaH / 0 °C
2: 1.) LDA
View Scheme
Multi-step reaction with 2 steps
1: NaH / 0 °C
2: 30 percent / 1.) n-BuLi / 1) -78 --> 0 deg C, several hours; 2) -78 --> RT
View Scheme
piperonal
120-57-0

piperonal

3,4-methylenedioxy-trans-cinnamic acid
2373-80-0

3,4-methylenedioxy-trans-cinnamic acid

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: pyridine; piperidine
2: ethanolic KOH-solution
View Scheme
Multi-step reaction with 2 steps
1: sodium hydride / tetrahydrofuran / 0 °C
2: potassium hydroxide; water / tetrahydrofuran
View Scheme
3,4-dihydroxybenzaldehyde
139-85-5

3,4-dihydroxybenzaldehyde

3,4-methylenedioxy-trans-cinnamic acid
2373-80-0

3,4-methylenedioxy-trans-cinnamic acid

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: potassium carbonate / 60 °C
2: pyridine; piperidine / 24 h / 80 °C
View Scheme
Multi-step reaction with 2 steps
1: potassium carbonate / acetone / 29 h / 50 - 60 °C
2: pyridine; piperidine / 24 h / 80 - 90 °C
View Scheme
Multi-step reaction with 2 steps
1.1: caesium carbonate / N,N-dimethyl-formamide / 24 h / 100 °C
2.1: pyridine / 0.17 h / 20 °C
2.2: 4 h / Reflux
View Scheme
Multi-step reaction with 2 steps
1: potassium carbonate / Reflux
2: pyridine; piperidine / 24 h / 80 °C
View Scheme
benzene-1,2-diol
120-80-9

benzene-1,2-diol

3,4-methylenedioxy-trans-cinnamic acid
2373-80-0

3,4-methylenedioxy-trans-cinnamic acid

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: sodium hydrogencarbonate / N,N-dimethyl-formamide / 12 h / 80 °C
2: acetic anhydride / isopropyl alcohol / 1 h / 55 - 110 °C
3: piperidine; pyridine / 2 h / 115 °C
View Scheme
Multi-step reaction with 3 steps
1.1: sodium hydrogencarbonate / N,N-dimethyl-formamide / 12 h / 80 °C
2.1: acetic anhydride / isopropyl alcohol / 0.5 h / 55 °C
2.2: 1 h / 110 °C
2.3: 3 h
3.1: pyridine; piperidine / 2 h / 115 °C
View Scheme
Methylenedioxybenzene
274-09-9

Methylenedioxybenzene

3,4-methylenedioxy-trans-cinnamic acid
2373-80-0

3,4-methylenedioxy-trans-cinnamic acid

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: acetic anhydride / isopropyl alcohol / 1 h / 55 - 110 °C
2: piperidine; pyridine / 2 h / 115 °C
View Scheme
Multi-step reaction with 2 steps
1.1: acetic anhydride / isopropyl alcohol / 0.5 h / 55 °C
1.2: 1 h / 110 °C
1.3: 3 h
2.1: pyridine; piperidine / 2 h / 115 °C
View Scheme
3,4-methylenedioxy-trans-cinnamic acid
2373-80-0

3,4-methylenedioxy-trans-cinnamic acid

3-(1,3 benzodioxol-5-yl)propionic acid
2815-95-4

3-(1,3 benzodioxol-5-yl)propionic acid

Conditions
ConditionsYield
With hydrogen; palladium on activated charcoal In N,N-dimethyl-formamide under 760 Torr; for 24h;100%
With palladium 10% on activated carbon; hydrogen; acetic acid In methanol at 20℃; for 22h;99%
With 10% Pd/C; cyclohexa-1,4-diene In methanol at 100℃; for 0.0833333h; Microwave irradiation;95%
3,4-methylenedioxy-trans-cinnamic acid
2373-80-0

3,4-methylenedioxy-trans-cinnamic acid

(E)-3-(1,3-benzodioxol-5-yl)acryloyl chloride
96249-87-5

(E)-3-(1,3-benzodioxol-5-yl)acryloyl chloride

Conditions
ConditionsYield
With oxalyl dichloride at 25℃; for 0.5h;100%
With oxalyl dichloride at 25℃; for 2h;100%
With oxalyl dichloride; N,N-dimethyl-formamide In dichloromethane at 0 - 20℃;100%
methanol
67-56-1

methanol

3,4-methylenedioxy-trans-cinnamic acid
2373-80-0

3,4-methylenedioxy-trans-cinnamic acid

methyl (2E)-3-(1,3-benzodioxol-5-yl)acrylate
40918-96-5

methyl (2E)-3-(1,3-benzodioxol-5-yl)acrylate

Conditions
ConditionsYield
With sulfuric acid Heating;99%
With sulfuric acid for 24h; Reflux;98%
With sulfuric acid for 0.166667h; Esterification; Irradiation;96%
3,4-methylenedioxy-trans-cinnamic acid
2373-80-0

3,4-methylenedioxy-trans-cinnamic acid

methyl (2E)-3-(1,3-benzodioxol-5-yl)acrylate
40918-96-5

methyl (2E)-3-(1,3-benzodioxol-5-yl)acrylate

Conditions
ConditionsYield
In methanol; diethyl ether at 20℃; for 0.25h; Inert atmosphere;99%
2 g
In methanol; diethyl ether at 0℃; for 0.666667h; Esterification;
4-Chloro-3,5-dimethylphenol
88-04-0

4-Chloro-3,5-dimethylphenol

3,4-methylenedioxy-trans-cinnamic acid
2373-80-0

3,4-methylenedioxy-trans-cinnamic acid

4-(benzo[d][1,3]dioxol-5-yl)-6-chloro-5,7-dimethyl-3,4-dihydrochromen-2-one
850496-03-6

4-(benzo[d][1,3]dioxol-5-yl)-6-chloro-5,7-dimethyl-3,4-dihydrochromen-2-one

Conditions
ConditionsYield
With trifluoroacetic acid for 23h;99%
With trifluoroacetic acid
methyl (2E)-3-(1,3-benzodioxol-5-yl)acrylate
40918-96-5

methyl (2E)-3-(1,3-benzodioxol-5-yl)acrylate

3,4-methylenedioxy-trans-cinnamic acid
2373-80-0

3,4-methylenedioxy-trans-cinnamic acid

Conditions
ConditionsYield
Stage #1: methyl (2E)-3-(1,3-benzodioxol-5-yl)acrylate With water; sodium hydroxide In tetrahydrofuran
Stage #2: With hydrogenchloride In water pH=< 3;
99%
With sodium hydroxide In tetrahydrofuran; methanol at 40℃; Inert atmosphere;81%
With potassium hydroxide In ethanol; water Heating;15 mg
piperonal
120-57-0

piperonal

malonic acid
141-82-2

malonic acid

3,4-methylenedioxy-trans-cinnamic acid
2373-80-0

3,4-methylenedioxy-trans-cinnamic acid

Conditions
ConditionsYield
With aluminum oxide; lithium chloride for 0.1h; Doebner condensation; microwave irradiation;98%
With piperidine; pyridine for 1h; Knoevenagel-Doebner-Stobbe Reaction; Reflux;98%
With ammonium acetate for 0.0666667h; Irradiation;97%
piperonal
120-57-0

piperonal

acetic acid
64-19-7

acetic acid

3,4-methylenedioxy-trans-cinnamic acid
2373-80-0

3,4-methylenedioxy-trans-cinnamic acid

Conditions
ConditionsYield
Stage #1: piperonal; acetic acid With titanium tetrachloride In dichloromethane at 25℃; for 0.333333h; Inert atmosphere;
Stage #2: With triethylamine In dichloromethane at 25℃; Inert atmosphere; stereoselective reaction;
98%
(2RS,3SR)-2,3-dibromo-3-(3,4-methylenedioxyphenyl)propanoic acid

(2RS,3SR)-2,3-dibromo-3-(3,4-methylenedioxyphenyl)propanoic acid

3,4-methylenedioxy-trans-cinnamic acid
2373-80-0

3,4-methylenedioxy-trans-cinnamic acid

Conditions
ConditionsYield
With zinc In acetic acid at 20℃; for 0.0166667h; microwave irradiation;96%
3,4-methylenedioxycinnamic acid benzhydryl ester
85580-21-8

3,4-methylenedioxycinnamic acid benzhydryl ester

3,4-methylenedioxy-trans-cinnamic acid
2373-80-0

3,4-methylenedioxy-trans-cinnamic acid

Conditions
ConditionsYield
With formic acid at 40 - 45℃; for 0.5h; Product distribution;89%
(E)-2'-hydroxy-3,4-methylenedioxychalcone
16669-99-1

(E)-2'-hydroxy-3,4-methylenedioxychalcone

3,4-methylenedioxy-trans-cinnamic acid
2373-80-0

3,4-methylenedioxy-trans-cinnamic acid

Conditions
ConditionsYield
With dihydrogen peroxide; potassium carbonate In acetonitrile at 20℃; for 5h;89%
piperonal
120-57-0

piperonal

malonic acid
141-82-2

malonic acid

A

5-vinyl-1,3-benzodioxole
7315-32-4

5-vinyl-1,3-benzodioxole

B

3,4-methylenedioxy-trans-cinnamic acid
2373-80-0

3,4-methylenedioxy-trans-cinnamic acid

Conditions
ConditionsYield
With pyridine; acetic acid at 130℃; for 0.133333h; Knoevenagel-Doebner reaction; microwave irradiation;A 4 % Spectr.
B 85%
piperonal
120-57-0

piperonal

acetic anhydride
108-24-7

acetic anhydride

3,4-methylenedioxy-trans-cinnamic acid
2373-80-0

3,4-methylenedioxy-trans-cinnamic acid

Conditions
ConditionsYield
With potassium acetate for 6h; Heating;50%
With sodium acetate
wikstromol
117824-56-3

wikstromol

Sodium; 3-benzo[1,3]dioxol-5-yl-2-iodo-propionate

Sodium; 3-benzo[1,3]dioxol-5-yl-2-iodo-propionate

A

4-Benzenesulfonylamino-2-benzo[1,3]dioxol-5-ylmethyl-4-oxo-3-(3,4,5-trimethoxy-benzyl)-butyric acid
118975-42-1

4-Benzenesulfonylamino-2-benzo[1,3]dioxol-5-ylmethyl-4-oxo-3-(3,4,5-trimethoxy-benzyl)-butyric acid

B

3,4-methylenedioxy-trans-cinnamic acid
2373-80-0

3,4-methylenedioxy-trans-cinnamic acid

Conditions
ConditionsYield
With n-butyllithium 1) -78 --> 0 deg C, several hours; 2) -78 --> RT; Yield given. Multistep reaction;A n/a
B 30%
piperonal
120-57-0

piperonal

sodium acetate
127-09-3

sodium acetate

acetic anhydride
108-24-7

acetic anhydride

3,4-methylenedioxy-trans-cinnamic acid
2373-80-0

3,4-methylenedioxy-trans-cinnamic acid

piperonal
120-57-0

piperonal

malonic acid
141-82-2

malonic acid

acetic acid
64-19-7

acetic acid

3,4-methylenedioxy-trans-cinnamic acid
2373-80-0

3,4-methylenedioxy-trans-cinnamic acid

piperonal
120-57-0

piperonal

ethyl acetate
141-78-6

ethyl acetate

3,4-methylenedioxy-trans-cinnamic acid
2373-80-0

3,4-methylenedioxy-trans-cinnamic acid

Conditions
ConditionsYield
With sodium Behandeln mit methylalkoholischer Kalilauge;
piperonal
120-57-0

piperonal

malonic acid
141-82-2

malonic acid

dimethyl amine
124-40-3

dimethyl amine

A

3-benzo[1,3]dioxol-5-yl-3-methylamino-propionic acid

3-benzo[1,3]dioxol-5-yl-3-methylamino-propionic acid

B

3,4-methylenedioxy-trans-cinnamic acid
2373-80-0

3,4-methylenedioxy-trans-cinnamic acid

ethyl (E)-3-(benzo[d][1,3]dioxol-5-yl)acrylate
24393-66-6

ethyl (E)-3-(benzo[d][1,3]dioxol-5-yl)acrylate

3,4-methylenedioxy-trans-cinnamic acid
2373-80-0

3,4-methylenedioxy-trans-cinnamic acid

Conditions
ConditionsYield
With potassium hydroxide
With water; potassium hydroxide In tetrahydrofuran
3-(3,4,5-trimethoxyphenyl)propanoic acid
25173-72-2

3-(3,4,5-trimethoxyphenyl)propanoic acid

Sodium; 3-benzo[1,3]dioxol-5-yl-2-iodo-propionate

Sodium; 3-benzo[1,3]dioxol-5-yl-2-iodo-propionate

A

2-piperonyl-3-(3,4,5-trimethoxy-benzyl)-succinic acid
139747-16-3

2-piperonyl-3-(3,4,5-trimethoxy-benzyl)-succinic acid

B

3,4-methylenedioxy-trans-cinnamic acid
2373-80-0

3,4-methylenedioxy-trans-cinnamic acid

Conditions
ConditionsYield
With lithium diisopropyl amide Yield given;
piperonal
120-57-0

piperonal

malonic acid
141-82-2

malonic acid

ammonia
7664-41-7

ammonia

3,4-methylenedioxy-trans-cinnamic acid
2373-80-0

3,4-methylenedioxy-trans-cinnamic acid

3-benzo<1,3>dioxol-5-acrylic acid isobutylamide

3-benzo<1,3>dioxol-5-acrylic acid isobutylamide

3,4-methylenedioxy-trans-cinnamic acid
2373-80-0

3,4-methylenedioxy-trans-cinnamic acid

Conditions
ConditionsYield
With potassium hydroxide
ethanol
64-17-5

ethanol

dihydrogen peroxide
7722-84-1

dihydrogen peroxide

4-benzo[1,3]dioxol-5-yl-2-oxo-but-3-enoic acid
69662-23-3

4-benzo[1,3]dioxol-5-yl-2-oxo-but-3-enoic acid

KOH-solution

KOH-solution

3,4-methylenedioxy-trans-cinnamic acid
2373-80-0

3,4-methylenedioxy-trans-cinnamic acid

potassium salt of/the/ piperonylidenepyruvic acid

potassium salt of/the/ piperonylidenepyruvic acid

3,4-methylenedioxy-trans-cinnamic acid
2373-80-0

3,4-methylenedioxy-trans-cinnamic acid

Conditions
ConditionsYield
With ethanol; dihydrogen peroxide
piperonal
120-57-0

piperonal

malonic acid
141-82-2

malonic acid

ammonia
7664-41-7

ammonia

A

piperonylidene-malonic acid
4436-15-1

piperonylidene-malonic acid

B

3,4-methylenedioxy-trans-cinnamic acid
2373-80-0

3,4-methylenedioxy-trans-cinnamic acid

C

β-amino-β-<3.4-methylenedioxy-phenyl>-propionic acid

β-amino-β-<3.4-methylenedioxy-phenyl>-propionic acid

caffeic acid
331-39-5

caffeic acid

3,4-methylenedioxy-trans-cinnamic acid
2373-80-0

3,4-methylenedioxy-trans-cinnamic acid

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 304 mg / conc. H2SO4 / 1 h / Heating
2: K2CO3, Cu0 / dimethylformamide / 1 h / Heating
3: 15 mg / KOH / ethanol; H2O / Heating
View Scheme
Methyl caffeate
3843-74-1, 67667-67-8

Methyl caffeate

3,4-methylenedioxy-trans-cinnamic acid
2373-80-0

3,4-methylenedioxy-trans-cinnamic acid

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: K2CO3, Cu0 / dimethylformamide / 1 h / Heating
2: 15 mg / KOH / ethanol; H2O / Heating
View Scheme
Multi-step reaction with 2 steps
1: potassium carbonate / N,N-dimethyl-formamide / 110 °C / Inert atmosphere
2: sodium hydroxide / methanol; tetrahydrofuran / 40 °C / Inert atmosphere
View Scheme
3-(1,3 benzodioxol-5-yl)propionic acid
2815-95-4

3-(1,3 benzodioxol-5-yl)propionic acid

3,4-methylenedioxy-trans-cinnamic acid
2373-80-0

3,4-methylenedioxy-trans-cinnamic acid

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 1.) LDA, 2.) CBr4 / 1) THF, -78 deg C (45 min), 0 deg C (3 1/4 h), RT (1 h); 2) THF, -78 deg C, 2 h
2: 92 percent / KI / acetone / 24 h / Heating
3: NaH / 0 °C
4: 1.) LDA
View Scheme
Multi-step reaction with 4 steps
1: 1.) LDA, 2.) CBr4 / 1) THF, -78 deg C (45 min), 0 deg C (3 1/4 h), RT (1 h); 2) THF, -78 deg C, 2 h
2: 92 percent / KI / acetone / 24 h / Heating
3: NaH / 0 °C
4: 30 percent / 1.) n-BuLi / 1) -78 --> 0 deg C, several hours; 2) -78 --> RT
View Scheme
Multi-step reaction with 3 steps
1: 1.) LDA, 2.) iodine / 1) THF, -78 deg C (45 min), 0 deg C (3 1/4 h), RT (1 h); 2) THF, -78 deg C, 10 min
2: NaH / 0 °C
3: 1.) LDA
View Scheme
Multi-step reaction with 3 steps
1: 1.) LDA, 2.) iodine / 1) THF, -78 deg C (45 min), 0 deg C (3 1/4 h), RT (1 h); 2) THF, -78 deg C, 10 min
2: NaH / 0 °C
3: 30 percent / 1.) n-BuLi / 1) -78 --> 0 deg C, several hours; 2) -78 --> RT
View Scheme
3-(3,4-methylenedioxyphenyl)-2-bromopropionic acid
56183-75-6

3-(3,4-methylenedioxyphenyl)-2-bromopropionic acid

3,4-methylenedioxy-trans-cinnamic acid
2373-80-0

3,4-methylenedioxy-trans-cinnamic acid

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 92 percent / KI / acetone / 24 h / Heating
2: NaH / 0 °C
3: 1.) LDA
View Scheme
Multi-step reaction with 3 steps
1: 92 percent / KI / acetone / 24 h / Heating
2: NaH / 0 °C
3: 30 percent / 1.) n-BuLi / 1) -78 --> 0 deg C, several hours; 2) -78 --> RT
View Scheme
3-Benzo[1,3]dioxol-5-yl-2-iodo-propionic acid
118975-38-5

3-Benzo[1,3]dioxol-5-yl-2-iodo-propionic acid

3,4-methylenedioxy-trans-cinnamic acid
2373-80-0

3,4-methylenedioxy-trans-cinnamic acid

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: NaH / 0 °C
2: 1.) LDA
View Scheme
Multi-step reaction with 2 steps
1: NaH / 0 °C
2: 30 percent / 1.) n-BuLi / 1) -78 --> 0 deg C, several hours; 2) -78 --> RT
View Scheme
piperonal
120-57-0

piperonal

3,4-methylenedioxy-trans-cinnamic acid
2373-80-0

3,4-methylenedioxy-trans-cinnamic acid

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: pyridine; piperidine
2: ethanolic KOH-solution
View Scheme
Multi-step reaction with 2 steps
1: sodium hydride / tetrahydrofuran / 0 °C
2: potassium hydroxide; water / tetrahydrofuran
View Scheme

2373-80-0Relevant articles and documents

Synthesis, characterization, antidepressant and antioxidant activity of novel piperamides bearing piperidine and piperazine analogues

Prashanth,Revanasiddappa, Hosakere D.,Lokanatha Rai,Veeresh

, p. 7065 - 7070 (2012)

A series of piperamide derivatives (8a-j) was synthesized with various substituted piperidine and piperazine compounds. The prepared compounds were evaluated for antibacterial activity against gram-positive and gram-negative bacteria and antifungal activity by disc diffusion method. The antioxidant activity of the compounds was evaluated by DPPH and superoxide radical scavenging method and antidepressant activity using forced swim and tail suspension behavioral despair tests in mice. The compounds 8a, 8b and 8c were investigated for their monoamine oxidase A and B (MAO-A and MAO-B) inhibitory property. Some of the test compounds were active in forced swim test (FST) and tail suspension test (TST). Compounds 8a and 8b showed a significant effect, when compared to standard drug, clorgyline.

4-Alkyliden-azetidinones modified with plant derived polyphenols: Antibacterial and antioxidant properties

Giacomini, Daria,Musumeci, Rosario,Galletti, Paola,Martelli, Giulia,Assennato, Lorenzo,Sacchetti, Gianni,Guerrini, Alessandra,Calaresu, Enrico,Martinelli, Marianna,Cocuzza, Clementina

, p. 604 - 614 (2017)

Antimicrobial resistance is one of the major and growing concerns in hospital- and community acquired infections, and new antimicrobial agents are therefore urgently required. It was reported that oxidative stress could contribute to the selection of resistant bacterial strains, since reactive oxygen species (ROS) revealed to be an essential driving force. In the present work 4-alkylidene-azetidinones, a new class of antibacterial agents, were functionalized with phytochemical polyphenolic acids such as protocatechuic, piperonyl, caffeic, ferulic, or sinapic acids and investigated as dual target antibacterial-antioxidant compounds. The best candidates showed good activities against multidrug resistant clinical isolates of MRSA (MICs 2–8 μg/mL). Among the new compounds, two revealed the best antioxidant capacity with TEAC-DPPH and TEAC-ABTS being significantly more active than Trolox.

Quorum sensing and nf-κb inhibition of synthetic coumaperine derivatives from piper nigrum

Baruch, Yifat,Gopas, Jacob,Kadosh, Yael,Kumar, Rajendran Saravana,Kushmaro, Ariel,Muthuraman, Subramani,Yaniv, Karin

supporting information, (2021/05/28)

Bacterial communication, termed Quorum Sensing (QS), is a promising target for virulence attenuation and the treatment of bacterial infections. Infections cause inflammation, a process regulated by a number of cellular factors, including the transcription Nuclear Factor kappa B (NF-κB); this factor is found to be upregulated in many inflammatory diseases, including those induced by bacterial infection. In this study, we tested 32 synthetic derivatives of coumaperine (CP), a known natural compound found in pepper (Piper nigrum), for Quorum Sensing Inhibition (QSI) and NF-κB inhibitory activities. Of the compounds tested, seven were found to have high QSI activity, three inhibited bacterial growth and five inhibited NF-κB. In addition, some of the CP compounds were active in more than one test. For example, compounds CP-286, CP-215 and CP-158 were not cytotoxic, inhibited NF-κB activation and QS but did not show antibacterial activity. CP-154 inhibited QS, decreased NF-κB activation and inhibited bacterial growth. Our results indicate that these synthetic molecules may provide a basis for further development of novel therapeutic agents against bacterial infections.

Dual Nickel/Ruthenium Strategy for Photoinduced Decarboxylative Cross-Coupling of α,β-Unsaturated Carboxylic Acids with Cycloketone Oxime Esters

Gao, Ang,Jiang, Run-Chuang,Liu, Chuang-Chuang,Liu, Qi-Le,Lu, Xiao-Yu,Xia, Ze-Jie

supporting information, p. 8829 - 8842 (2021/06/30)

Herein, a dual nickel/ruthenium strategy is developed for photoinduced decarboxylative cross-coupling between α,β-unsaturated carboxylic acids and cycloketone oxime esters. The reaction mechanism is distinct from previous photoinduced decarboxylation of α,β-unsaturated carboxylic acids. This reaction might proceed through a nickelacyclopropane intermediate. The C(sp2)-C(sp3) bond constructed by the aforementioned reaction provides an efficient approach to obtaining various cyanoalkyl alkenes, which are synthetically valuable organic skeletons in organic and medicinal chemistry, under mild reaction conditions. The protocol tolerates many critical functional groups and provides a route for the modification of complex organic molecules.

Simplified Derivatives of Dibenzylbutyrolactone Lignans from Hydrocotyle bonariensis as Antitrypanosomal Candidates

Souza, Dalete Christine S.,Costa-Silva, Thais A.,Morais, Thiago R.,Brito, Juliana R.,Ferreira, Edgard A.,Antar, Guilherme M.,Sartorelli, Patricia,Tempone, Andre G.,Lago, Jo?o Henrique G.

, (2021/10/01)

The search for the pharmacophore of a bioactive compound, crucial for drug discovery studies, involves the adequate arrangement of different atoms in the molecule. As part of a continuous work aiming discovery of new drug candidates against the protozoan parasite Trypanosoma cruzi, the hexane extract of Hydrocotyle bonariensis was subjected to a bioactivity-guided fractionation to afford two chemically related dibenzylbutyrolactone lignans – hinokinin (1) and hibalactone (2). Compounds 1 and 2 showed activity against trypomastigote with EC50 values of 17.0 and 69.4 μM, respectively. Compound 1 was also active against the clinically relevant form of the parasite, amastigotes, displaying an EC50 value of 34.4 μM. The structure-activity relationship (SAR) indicated that the absence of the double bond at C-7 is a crucial feature for the increment of the antiparasitic activity. The lethal action of the most potent compound 1 was investigated in the trypomastigotes. The fluorescent-based assay with SYTOX Green demonstrated a significant alteration of the plasma membrane permeability of the parasite. Additionally, compound 1 demonstrated no significant hemolytic activity in mice erythrocytes at 200 μM. To search the pharmacophore, three different simplified compounds – 3,4-methylenedioxydihydrocinnamic acid (3), 3,4-methylenedioxydihydrocinnamic alcohol (4) and 3,4-methylenedioxycinnamic acid (5) – were prepared and tested against T. cruzi. These derivatives displayed EC50 values of 37.2 (3), 25.8 (4) and 73.5 (5) μM against trypomastigotes, and 41.3 (3) and 48.2 (4) μM against amastigotes, whereas compound 5 was inactive. Except for compound 2, which resulted in a CC50 value of 114.5 μM, all compounds showed no mammalian cytotoxicity at 200 μM. An in silico ADMET study was performed and predicted values demonstrated an acceptable drug-likeness profile for compounds 1–5. Despite the minor reduction in the potency, the simplified derivatives retained the antitrypanosomal activity against the intracellular amastigotes, even with 95 % reduction of their molecular weight. Additionally, in silico studies suggested them as more soluble compounds, making these simplified structures promising scaffolds for optimization studies in Chagas disease.

Identification of novel functionalized carbohydrazonamides designed as chagas disease drug candidates

Do Nascimento, Mayara S. S.,Camara, Vitória R. F.,da Costa, Juliana S.,Barbosa, Juliana M. C.,Lins, Alessandra S. M.,Salom?o, Kelly,de Castro, Solange L.,Carvalho, Samir A.,da Silva, Edson F.,Fraga, Carlos A. M.

, p. 774 - 783 (2020/08/19)

Background: Although several research efforts have been made worldwide to discover novel drug candidates for the treatment of Chagas disease, the nitroimidazole drug benznidazol remains the only therapeutic alternative in the control of this disease. However, this drug presents reduced efficacy in the chronic form of the disease and limited safety after long periods of admini-stration, making it necessary to search for new, more potent and safe prototypes. Objective: We described herein the synthesis and the trypanocidalaction of new functionalized carbohydrazonamides (2-10) against trypomastigote forms of Trypanosoma cruzi. Methods: These compounds were designed through the application of molecular hybridization concept between two potent anti-T. cruzi prototypes, the nitroimidazole derivative megazol (1) and the cinnamyl N-acylhydrazone derivative (14) which have been shown to be twice as potent in vitro as benznidazole. Results: The most active compounds were the (Z)-N'-((E)-3-(4-nitrophenyl)-acryloyl)-1-methyl-5-nitro-1H-imidazol-2-carbohydrazonamide (6) (IC50 =9.50 μM) and the (Z)-N'-((E)-3-(4-hydroxyphe-nyl)-acryloyl)-1-methyl-5-nitro-1H-imidazol-2-carbohydrazonamide (8) (IC50 =12.85 μM), which were almost equipotent to benznidazole (IC50 =10.26 μM) used as standard drug. The removal of the amine group attached to the imine subunit in the corresponding N-acylhydrazone derivatives (11-13) resulted in less potent or inactive compounds. The para-hydroxyphenyl derivative (8) presented also a good selectivity index (SI = 32.94) when tested against mammalian cells from Swiss mice. Conclusion: The promising trypanocidal profile of new carbohydrazonamide derivatives (6) and (8) was characterized. These compounds have proved to be a good starting point for the design of more effective trypanocidal drug candidates.

Identification and optimization of piperine analogues as neuroprotective agents for the treatment of Parkinson's disease via the activation of Nrf2/keap1 pathway

Cai, Xiaoying,Chen, Lijuan,Hong, Feng,Kuang, Shuang,Li, Yan,Ma, Xu,Qi, Wenyan,Shi, Mingsong,Wang, Lun,Xu, Ruiling,Xue, Linlin,Ye, Haoyu,Zhang, Ruijia

, (2020/05/11)

Parkinson's disease (PD) is a slowly progressive and complex neurodegenerative disorder. Up to date, there are no approved drugs that could slow or reverse the neurodegenerative process of PD. Here, we reported the synthesis of series of piperine analogues and the evaluation of their neuroprotective effects against hydrogen peroxide (H2O2) induced damage in the neuron-like PC12 cells. Among these analogues, 3b exhibited the most potent protection effect and its underlying mechanism was further investigated. Further results indicated that the ROS scavenging and cytoprotection effect of 3b might be related to the Nrf2 activation and upregulation of related phase II antioxidant enzymes, such as HO-1 and NQO1. In in vivo study, oral administration (100 mg/kg) of 3b significantly attenuated PD-associated behavioral deficits in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced mouse model of PD and protected tyrosine hydroxylase-immunopositive dopaminergic neurons. Our results provided evidence that 3b might be a promising candidate for Parkinson's disease treatment.

Synthesis and antimicrobial evaluation of piperic acid amides and their lower homologues

Achanta, Prabhakar S.,Raj, Sneha,Horam, Soyar,Arockiaraj, Jesu,Bobbala, Ravi Kumar,Akkinepally, Raghuram Rao,Pasupuleti, Mukesh,Achanta, Appa Rao V. N.

, p. 366 - 373 (2019/12/12)

Seven piperic acid amides along with their lower homologs (12) were synthesized using HATU-DIPEA coupling reagent. All the synthesized derivatives were evaluated for their antibacterial activities against Staphylococcus aureus, Pseudomonas aeruginosa, and vancomycin-resistant P. aeruginosa. They were found to be more active on P. aeruginosa than on S. aureus. However, they did not exhibit potent activity on Vancomycin resistant P. aeruginosa. Among the tested compounds, methylenedioxycinnamic acid amide of anthranilic acid (MDCA-AA, 2a) was found to be most active against S. aureus with MIC of 3.125 μg/ml. The PAS and INH amides of piperic acid were screened against Mycobacterium tuberculosis H37Ra strain. They were found to be most active among all the tested compounds but were found to be less active than the standard drug, isoniazid.

Piperine derivative as well as preparation method and application thereof

-

Paragraph 0255; 0257-0259, (2020/05/08)

The invention provides a piperine derivative as well as a preparation method and an application thereof. The piperine derivative is a compound shown as a formula (I), or a salt thereof, or a stereoisomer thereof, or a hydrate thereof. The compound provided by the invention can effectively protect nerve cells and improve the survival rate of the nerve cells, so that the compound provided by the invention can effectively treat neurodegenerative diseases and can be used for preparing medicines for treating the neurodegenerative diseases.

Mild, Metal-Free and Protection-Free Transamidation of N-Acyl-2-piperidones to Amino Acids, Amino Alcohols and Aliphatic Amines and Esterification of N-Acyl-2-piperidones

Subramani, Muthuraman,Rajendran, Saravana Kumar

supporting information, p. 3677 - 3686 (2019/06/08)

Amides are indispensable building blocks of biological systems, pharmaceuticals, and materials. We report a highly selective method for the synthesis of amides via transamidation process. Transamidation of N-acyl-2-piperidones with a broad range of amines is demonstrated under exceedingly mild and metal-free reaction condition that relies on the amide bond twist to weaken the amidic resonance. Transamidation proceeds under the neat condition at room temperature, in short reaction times (30–90 min) with good yields. Considerable variation is tolerated with both amine and imide substrates. Of note, amines bearing carboxylic acids (glycine and serine) and hydroxyl groups (dopamine, tyramine, etc.) are well tolerated which are otherwise problematic under the metal-catalyzed protocol. Our current method is applicable for transamidation of both alkyl and aryl-N-acyl-2-piperidones. The practical value of the method is highlighted by the synthesis of four natural product amide alkaloids in high yields under mild reaction conditions. In the absence of nucleophilic amines, N-acyl-2-piperidones undergoes esterification with EtOH at elevated temperature. Single crystal X-ray analysis of an N-acyl-2-piperidone shows amide bond twist, τ = –20.39° and pyramidalization, χN = –11.73°. This weakens the amidic conjugation and might be the factor controlling the reactivity and selectivity of these imides. We envision that the N-acyl-2-piperidone scaffold would be useful in the synthesis of pharmaceuticals and materials.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 2373-80-0